Reynolds Capital Management’s Gilead Sciences GILD Stock Holding History

Reynolds Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$220K	Sell	2,400 -1,800	-43%	-$162K	0.38%	93
2015 Q4	$425K	Sell	4,200 -4,300	-51%	-$447K	0.46%	67
2015 Q3	$835K	Sell	8,500 -100	-1%	-$11.1K	1.05%	22
2015 Q2	$1.01M	Sell	8,600 -1,900	-18%	-$208K	0.99%	13
2015 Q1	$1.03M	Sell	10,500 -3,800	-27%	-$386K	0.9%	18
2014 Q4	$1.35M	Sell	14,300 -8,000	-36%	-$827K	1.12%	9
2014 Q3	$2.37M	Buy	22,300 +4,700	+27%	+$460K	2.3%	3
2014 Q2	$1.46M	Sell	17,600 -200	-1%	-$15.6K	0.99%	5
2014 Q1	$1.26M	Sell	17,800 -2,300	-11%	-$180K	0.81%	5
2013 Q4	$1.51M	Buy	20,100 +1,400	+7%	+$97.5K	0.85%	7
2013 Q3	$1.18M	Buy	18,700 +300	+2%	+$17.9K	0.76%	9
2013 Q2	$944K	Buy	+18,400	New	+$959K	0.69%	10

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Reynolds Capital Management's GILD Position: Q1 2016 in Review

Reynolds Capital Management reduced its Gilead Sciences (GILD) stake by 43% in Q1 2016, selling an estimated $162K and leaving 2,400 shares worth $220K. The position accounts for 0.38% of the portfolio, ranked #93.

Reynolds Capital Management first reported a position in GILD in Q2 2013 and has held it in 12 quarters since. The position peaked at $2.37M in Q3 2014. 1,630 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

Reynolds Capital Management held 2,400 shares of Gilead Sciences worth $220K as of Q1 2016.
Reynolds Capital Management sold 1,800 Gilead Sciences shares in Q1 2016, an estimated $162K.
Gilead Sciences made up 0.38% of Reynolds Capital Management's portfolio in Q1 2016, its #93 holding.
Reynolds Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 12 quarters since.
Reynolds Capital Management's Gilead Sciences position peaked at $2.37M in Q3 2014.
1,630 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Reynolds Capital Management's 13F filing for Q1 2016, filed 13 May 2016.